Cell and gene therapies provide unique market access and pricing challenges. Chaired by Valid insight, a panel of EU and US industry and payer experts discuss opportunities for developing optimal market access strategies for cell and gene therapies. Complete the form to watch the webinar now.
- Chris Bojke, Professor of Health Economics At Leeds University
- Gianluigi Casadei, Adjunct Professor, Università degli Studi di Milano